Skip to main content

Advertisement

Figure 6 | Molecular Cancer

Figure 6

From: Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma

Figure 6

Maximal inhibition of the established HCC under the combination therapy. Tumor size was monitored on day 1 to 9 post-treatment (A) and mice were sacrificed and the entire tumor was weighed (B). Gelatin zymography was used to detect intratumoral MMP-2 and MMP-9 activity (C). Control: control group; SLC: SLC group; SLC + anti-CD25: combination therapy group. Values were presented as mean ± SD; n = 5 mice/group. * P < 0.05, ** P < 0.01 vs control or indicated comparison on day 1 to 9. Results were obtained in three independent experiments;

Back to article page